Charles River Laboratories International, Inc.
CRL
$155.46
$2.801.83%
NYSE
| 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 213.77M | 207.10M | 182.82M | 229.36M | 194.61M |
| Total Receivables | 708.86M | 734.48M | 767.57M | 756.63M | 720.92M |
| Inventory | 299.10M | 302.55M | 279.55M | 290.16M | 278.54M |
| Prepaid Expenses | 96.11M | 121.54M | 110.00M | 129.99M | 103.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 129.21M | 166.44M | 129.92M | 100.23M | 105.80M |
| Total Current Assets | 1.45B | 1.53B | 1.47B | 1.51B | 1.40B |
|
|
|||||
| Total Current Assets | 1.45B | 1.53B | 1.47B | 1.51B | 1.40B |
| Net Property, Plant & Equipment | 2.02B | 1.97B | 1.99B | 1.99B | 2.02B |
| Long-term Investments | 2.76B | 2.92B | 2.94B | 2.87B | 2.85B |
| Goodwill | 2.76B | 2.92B | 2.94B | 2.87B | 2.85B |
| Total Other Intangibles | 340.00M | 571.09M | 602.45M | 655.71M | 723.40M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 360.52M | 327.80M | 343.40M | 342.90M | 320.41M |
| Total Assets | 7.14B | 7.51B | 7.56B | 7.58B | 7.53B |
|
|
|||||
| Total Accounts Payable | 148.80M | 169.62M | 145.80M | 149.33M | 140.34M |
| Total Accrued Expenses | 508.94M | 470.53M | 432.95M | 414.79M | 367.33M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 61.06M | 2.64M | 2.93M | 3.47M | 57.09M |
| Total Finance Division Other Current Liabilities | 401.52M | 479.11M | 498.76M | 483.46M | 429.35M |
| Total Other Current Liabilities | 401.52M | 479.11M | 498.76M | 483.46M | 429.35M |
| Total Current Liabilities | 1.12B | 1.12B | 1.08B | 1.05B | 994.10M |
|
|
|||||
| Total Current Liabilities | 1.12B | 1.12B | 1.08B | 1.05B | 994.10M |
| Long-Term Debt | 2.11B | 2.16B | 2.31B | 2.49B | 2.21B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 458.70M | 468.66M | 479.38M | 500.82M | 509.46M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 233.51M | 312.47M | 294.48M | 303.66M | 302.17M |
| Total Liabilities | 3.92B | 4.06B | 4.16B | 4.34B | 4.02B |
|
|
|||||
| Common Stock & APIC | 1.95B | 2.02B | 1.99B | 1.98B | 1.97B |
| Retained Earnings | 1.39B | 1.94B | 1.89B | 1.84B | 1.81B |
| Treasury Stock & Other | -171.78M | -555.05M | -529.81M | -621.80M | -317.35M |
| Total Common Equity | 3.16B | 3.41B | 3.35B | 3.19B | 3.46B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.16B | 3.41B | 3.35B | 3.19B | 3.46B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 46.56M | 45.37M | 46.27M | 47.45M | 46.58M |
| Total Equity | 3.21B | 3.45B | 3.40B | 3.24B | 3.51B |
|
|
|||||